BAGEP 2016 winner molecular biologist Umut Şahin from Boğaziçi University is among the Gilead Turkey Fellowship Award winners in 2016.
The Gilead Turkey Fellowship Program started in 2013 to support innovative ideas and research projects in HIV, viral hepatitis, hematological malignancies and fungal diseases. Financial grants are awarded on a competitive basis to healhcare professionals and researchers in life sciences.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines. Gilead’s portfolio of products includes treatments for HIV/AIDS, cancer, viral hepatitis and cardiovascular conditions.
Umut Şahin (PhD), together with Fehmi Tabak (MD) from Istanbul University Faculty of Medicine were awarded in the category of HIV for their proposal to investigate host-pathogen interactions at cellular and genetic level in HIV-infected individuals.